PTPI - Petros Pharmaceuticals, Inc.
0.0664
-0.058 -86.747%
Share volume: 266,556,737
Last Updated: 05-21-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.12
-0.06
-0.46%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-13-2024 | 05-15-2025 | |
| Total revenue | 1.389 M | 1.421 M | 1.576 M | 0.000 | |
| Cost of revenue | 331.831 K | 329.110 K | 287.005 K | 0.000 | |
| Gross profit | 1.057 M | 1.092 M | 1.289 M | 0.000 | |
| 3.35% | 18.03% | -100.00% | |||
| Operating expenses | 4.267 M | 2.655 M | 2.890 M | 1.458 M | |
| Selling general and admin | 2.711 M | 2.287 M | 2.301 M | 1.458 M | |
| Research and development | 1.556 M | 368.798 K | 588.355 K | 0.000 | |
| Total expenses | 4.985 M | 3.373 M | 3.629 M | 1.458 M | |
| -32.34% | 7.58% | -59.82% | |||
| Operating income | -3.928 M | -2.281 M | -2.340 M | -1.458 M | |
| Ebit | -2.194 M | -666.905 K | -2.138 M | -1.247 M | |
| Pretax income | -2.163 M | -662.026 K | -2.221 M | -1.200 M | |
| -69.39% | 235.43% | -45.98% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.163 M | -662.026 K | -2.221 M | -2.260 M | |
| 69.39% | -235.43% | -1.77% |